Special Investigation (Long-term Investigation) in Patients With Crohn's Disease

Trial Profile

Special Investigation (Long-term Investigation) in Patients With Crohn's Disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Apr 2018

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Crohn's disease
  • Focus Adverse reactions
  • Sponsors Abbott Laboratories; AbbVie
  • Most Recent Events

    • 12 Apr 2018 Status changed from active, no longer recruiting to completed.
    • 30 Jan 2018 Planned End Date changed from 31 Oct 2018 to 31 Mar 2018.
    • 30 Jan 2018 Planned primary completion date changed from 31 Oct 2018 to 31 Mar 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top